Parents' experiences of pediatric hematopoietic stem cell transplantation: A systematic review and meta-synthesis

Maryam Maleki1, Abbas Mardani1, Mojtaba Vaismoradi2

  • 1Social Determinants of Health Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.

PubMed

Insights

Parents of children undergoing hematopoietic stem cell transplantation (HSCT) face significant caregiver burden. Holistic, family-centered care is essential to support parents

Area of Science:

  • Pediatric Hematology
  • Oncology
  • Stem Cell Transplantation
  • Family Caregiving
  • Psychosocial Support

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a critical treatment for pediatric malignancies and genetic disorders.
  • Parents experience substantial emotional, psychological, and practical burdens during their child's HSCT journey.
  • Understanding these parental experiences is vital for developing effective support systems.

Purpose of the Study:

  • To synthesize and analyze existing evidence on parents' experiences with pediatric HSCT.
  • To gain a comprehensive understanding of the challenges and needs of parents during their child's HSCT.
  • To inform the development of family-centered care models.

Main Methods:

  • Systematic review with a meta-synthesis approach.
  • Searched five major databases (PubMed, Scopus, CINAHL, Web of Science, Embase) without time restrictions.
  • Included qualitative studies and qualitative components of mixed-methods studies focusing on parental experiences.

Main Results:

  • Included 24 qualitative and 1 mixed-methods study.
  • Identified five key themes: caregiver burden, support systems, family dynamics, coping strategies, and positive outcomes.
  • Highlighted the multifaceted nature of parental experiences during pediatric HSCT.

Conclusions:

  • Parents undergoing pediatric HSCT face significant challenges but also experience growth opportunities.
  • Emphasizes the need for holistic, family-centered care to alleviate caregiver burden and enhance support.
  • Calls for healthcare providers and policymakers to implement supportive measures, including mental health services and financial aid.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K